Skip to main content
. 2021 Jun 25;28(13):8688–8696. doi: 10.1245/s10434-021-10319-0

Table 1.

Cohort demographics (N = 21)

Breast cancer (N = 8) Prostate cancer (N = 13)
Age, median (IQR) 66 years (58–68.5 years) 61 years (58–65 years)
Gender
Male 8 (100%) 13 (100%)
Female
Race/ethnicity
White, non-Hispanic 8 (100%) 10 (76.9%)
White, Hispanic 2 (15.4%)
Asian American 1 (7.7%)
Married 6 (75%) 13 (100%)
Primary insurance provider
Employer-sponsored Insurance 4 (50%) 6 (30.8%)
Medicare 4 (50%) 4 (46.2%)
Tricare 1 (7.7%)
Medicaid 2 (15.4%)
Breast cancer stage
Ductal carcinoma in situ (DCIS) 1 (12.5%)
Stage I, estrogen-receptor+ (ER+) 7 (87.5%)
Prostate cancer grade
High grade 1 (7.7%)
Intermediate grade 10 (76.9%)
Low grade 2 (15.4%)
Surgery
Lumpectomy 6 (75%)
Double mastectomy 2 (25%)
Prostatectomy 13 (100%)